Regulatory overview for OTC syrup packaging for EU market

02 October 2017

The regulatory environment has a great impact on business, especially in healthcare. Non-compliance exposes companies to the risk of launch delay, delisting products from the market and out-of-stocks. Moreover, it can cause reputational damage affecting staff, consumer and shareholder confidence, reduce market opportunities, and affect the bottom line. This article, written by Piotr Zaborniak of GlaxoSmithKline (GSK), gives a compact overview of the current regulatory requirements in Europe for Over The Counter (OTC) syrup packaging. It covers subjects like the authorisation process, the Medical Devices Directive, and Directive 2001/83/EC (European Pharmaceutical Review, 21 August 2017).
Click here to read the article.
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.